Skip to main content
. 2018 Apr 13;14(6):1489–1500. doi: 10.1080/21645515.2018.1442996

Figure 2.

Figure 2.

Anti-pneumococcal antibody concentrations and OPA titers after primary vaccination with PHiD-CV (with or without RTS,S/AS01 co-administration) and booster vaccination (according to protocol immunogenicity cohort at each time point). Vertical lines indicate 95% confidence intervals, OPA = opsonophagocytic activity, PHiD-CV = 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine, GMC/T = geometric mean antibody concentration/titer.